AGIO
Price
$34.33
Change
+$0.75 (+2.23%)
Updated
Jun 6 closing price
Capitalization
1.94B
53 days until earnings call
MNPR
Price
$37.11
Change
-$0.90 (-2.37%)
Updated
Jun 6 closing price
Capitalization
232.47M
Interact to see
Advertisement

AGIO vs MNPR

Header iconAGIO vs MNPR Comparison
Open Charts AGIO vs MNPRBanner chart's image
Agios Pharmaceuticals
Price$34.33
Change+$0.75 (+2.23%)
Volume$377.3K
Capitalization1.94B
Monopar Therapeutics
Price$37.11
Change-$0.90 (-2.37%)
Volume$19.86K
Capitalization232.47M
AGIO vs MNPR Comparison Chart
Loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGIO vs. MNPR commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a Buy and MNPR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (AGIO: $30.83 vs. MNPR: $32.46)
Brand notoriety: AGIO and MNPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 90% vs. MNPR: 154%
Market capitalization -- AGIO: $1.94B vs. MNPR: $232.47M
AGIO [@Biotechnology] is valued at $1.94B. MNPR’s [@Biotechnology] market capitalization is $232.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 1 FA rating(s) are green whileMNPR’s FA Score has 0 green FA rating(s).

  • AGIO’s FA Score: 1 green, 4 red.
  • MNPR’s FA Score: 0 green, 5 red.
According to our system of comparison, AGIO is a better buy in the long-term than MNPR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 6 TA indicator(s) are bullish while MNPR’s TA Score has 4 bullish TA indicator(s).

  • AGIO’s TA Score: 6 bullish, 3 bearish.
  • MNPR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AGIO is a better buy in the short-term than MNPR.

Price Growth

AGIO (@Biotechnology) experienced а +2.39% price change this week, while MNPR (@Biotechnology) price change was -8.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

AGIO is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGIO($1.95B) has a higher market cap than MNPR($232M). MNPR YTD gains are higher at: 47.545 vs. AGIO (-6.178). MNPR has higher annual earnings (EBITDA): -7M vs. AGIO (-420.08M). AGIO has more cash in the bank: 894M vs. MNPR (6.02M). MNPR has less debt than AGIO: MNPR (0) vs AGIO (57M). AGIO has higher revenues than MNPR: AGIO (36.5M) vs MNPR (0).
AGIOMNPRAGIO / MNPR
Capitalization1.95B232M838%
EBITDA-420.08M-7M6,002%
Gain YTD-6.17847.545-13%
P/E Ratio2.91N/A-
Revenue36.5M0-
Total Cash894M6.02M14,850%
Total Debt57M0-
FUNDAMENTALS RATINGS
AGIO: Fundamental Ratings
AGIO
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
18
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGIOMNPR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
77%
Bullish Trend 12 days ago
81%
Momentum
ODDS (%)
Bullish Trend 12 days ago
78%
Bearish Trend 12 days ago
86%
MACD
ODDS (%)
Bullish Trend 12 days ago
70%
Bearish Trend 12 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
77%
Bearish Trend 12 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
79%
Bearish Trend 12 days ago
88%
Advances
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 25 days ago
82%
Declines
ODDS (%)
Bearish Trend 18 days ago
77%
Bearish Trend 12 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
78%
Bullish Trend 12 days ago
85%
Aroon
ODDS (%)
Bullish Trend 12 days ago
71%
Bullish Trend 12 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

AGIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGIO has been loosely correlated with OLMA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AGIO jumps, then OLMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGIO
1D Price
Change %
AGIO100%
+2.09%
OLMA - AGIO
47%
Loosely correlated
-3.69%
INSM - AGIO
46%
Loosely correlated
-2.44%
CRNX - AGIO
43%
Loosely correlated
+1.39%
KYMR - AGIO
42%
Loosely correlated
+2.35%
LGND - AGIO
42%
Loosely correlated
-1.43%
More

MNPR and

Correlation & Price change

A.I.dvisor tells us that MNPR and QNCX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MNPR and QNCX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNPR
1D Price
Change %
MNPR100%
-7.91%
QNCX - MNPR
32%
Poorly correlated
+3.92%
CVKD - MNPR
29%
Poorly correlated
-2.04%
RAPT - MNPR
26%
Poorly correlated
-0.30%
NEUP - MNPR
25%
Poorly correlated
-3.26%
AGIO - MNPR
25%
Poorly correlated
+2.09%
More